Ñomparative efficiency of neuroprotective, glutamatergic and complex therapy of patients with vascular dementia

Similar documents
ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

Nutritional intervention in early Alzheimer s disease. Sasha Newsam, PhD Global Medical Affairs Manager Nutricia

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

NEUROPSYCHOMETRIC TESTS

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?

Drug Update. Treatments for Cognitive Impairment in the Older Adult. William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS

disease. The study included 75 patients aged years with chronic cerebral ischemia. Neuropsychological

Dementia of the Alzheimer Type: the Drug Treatment Debate

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends

Statins and Cognition A Focus on Mechanisms

ORIGINAL CONTRIBUTION. Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Anxiety, Depression, and Dementia/Alzheimer Disease: What are the Links?

The Role of POLST in the Care of People with Dementia

Cognitive Assessment 4/29/2015. Learning Objectives To be able to:

Trajectories of different cognitive domains in community-dwelling older adults

Psychosis in the Elderlyy

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Chronicity and Aging: The Geriatric Imperative

ORIGINAL CONTRIBUTION. History of Vascular Disease and Mild Parkinsonian Signs in Community-Dwelling Elderly Individuals

Practical upates in Diabetes & CV risk management: Brief Updates Neurological complications in diabetes

Presence and severity of carotid siphon calcification on computed tomography images in mild cognitive impairment

Lambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Dementia and Intellectual and Developmental Disabilities

Dementia Diagnosis Guidelines Primary Care

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

Jung Wan Kim* Department of Speech Pathology of Daegu University, Gyeongsan, South Korea

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

Alzheimer s Disease Update: From Treatment to Prevention

SUPPLEMENTAL MATERIAL

Report of Children with Disabilities (IDEA) Ages 6 through 21 by Disability, Educational Environment, and Age Group (OSEP010)

Continence, falls and the frailty syndrome. Anne Foley - BGS Bladders and Bowel Health 2012

Alzheimer s disease dementia: a neuropsychological approach

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Confusional state. Digit Span. Mini Mental State Examination MMSE. confusional state MRI

Chronic Diseases in the Elderly. Steven L. Phillips, MD Medical Director Sanford Center for Aging University of Nevada, Reno

Recognizing Signs and Symptoms of Alzheimer's Disease in Earlier Stages Can Lead to Diagnosis

TOPF (Test of Pre-Morbid Function)

T H E B E T T E R H E A L T H N E W S

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

CTFPHC Working Group Members:

HAWAII HEALTHCARE PROFESSIONAL DEMENTIA CURRICULUM,

Mentis Cura November

Exercise and Lifestyle Factors Can cognitive decline & dementia be prevented? Henry Brodaty

EPILESSIA Epidemiologia e inquadramento diagnostico. Ettore Beghi IRCCS Istituto Mario Negri, Milano

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School

A Review on Relationship between Type II Diabetes and Cognitive Impairment

How does exercise benefit people at risk for dementia?

Executive Summary. The Royal Australasian College of Physicians July 2012 Page 1 of 5

Factors and Clinical Management

Dementia Prepared by: Joanne Leung Psychiatry Resident, University of Toronto

Outline. Minority Issues in Aging Research. The Role of Research in the Clinical Setting. Why Participate in Research

Falls: Cognitive Motor Perspectives

How complicated is diabetes? Jonathan Shaw

Dementia and Diabetes

Quality ID #291: Parkinson s Disease: Cognitive Impairment or Dysfunction Assessment National Quality Strategy Domain: Effective Clinical Care

A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials

Dementia and Cognition in Older Adults: Year in Review

Application of Item Response Theory to ADAS-cog Scores Modeling in Alzheimer s Disease

Setting The setting was institutional and tertiary care in London, Essex and Hertfordshire in the UK.

Prevention, health promotion & early intervention in dementia

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Relationship of Hearing Impairment to Dementia and Cognitive Dysfunction

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS

Published in the Russian Federation European Journal of Medicine. Series B Has been issued since ISSN: Vol. 2, Is. 1, pp.

Erin Cullnan Research Assistant, University of Illinois at Chicago

Original Articles. Calne, resting tremor. Mortimer, Pirozzolo, Hansch, & Webster, postural disturbance III

Key Findings. Friday Harbor Psychometrics Workshop Aug 22 27, Canadian Study of Health and Aging

David A Scott Lis Evered. Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne

A Neuropsychiatric, Neuroradiological, and Neuropsychological Profile of a Cohort of Patients with Vascular Dementia

THE ASSOCIATION BETWEEN CHOLESTEROL LEVELS AND BRACHIAL/AORTIC AUGMENTATION INDEX VERSUS COGNITIVE STATUS IN PATIENTS WITH CARDIOVASCULAR RISK FACTORS

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

WEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES

Seminar on Dementia: Mission Possible

Critical Path Institute Coalition Against Major Diseases (CAMD) Alzheimer s Clinical Trial Database

The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): study description and preliminary data

Driving and Dementia. By Alison Morris OT.

ORIGINAL CONTRIBUTION. Detecting Dementia With the Mini-Mental State Examination in Highly Educated Individuals

Recommendations on Screening for Cognitive Impairment in Older Adults 2015

MEDICAL LIFESTYLE INTERVENTIONS FOR BRAIN HEALTH

Petra Bevilacqua Psychologist

DEPRESSIVE SYMPTOMS IN ADULT CHILD CAREGIVERS OF VERY OLD MEXICAN AMERICANS: A STUDY OF THE HEPESE

Recognizing Alzheimer's Disease at the Earliest Stages: Key Signs and Symptoms

Tourists with Dementia A Unique Challenge for the Tourism Industry

Could physical activity delay cognitive decline in older adults with vascular risk factors? The AIBL active study

Social inequalities in dementia care, cure, and research

Longevity - loneliness, dependency, malnutrition and geriatric giants in 12,210 elderly hospitalized people

STOP, LOOK AND LISTEN: Supporting people with dementia and their families at the end of life

Mild Cognitive Impairment Symposium January 19 and 20, 2013

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

EFFECTIVE COMMUNICATION: HEALTHCARE

Hyperinsulinemia, Insulin Resistance and Cognitive Decline in Older Cohort *

Fighting Polypharmacy - From Theory to Practice :

Access to Proven Therapies

Can lowering blood pressure and cholesterol after stroke prevent cognitive decline?

Transcription:

Journal of research in health science 2018 ¹ 1 (2), Januar-April www.journalofresearch.org; info@journalofresearch.org DOI 10.26739/2523-1243 ISSN Print: 2523-1243; ISSN Online: 2523-1251 Ñomparative efficiency of neuroprotective, glutamatergic and complex of patients with vascular Maksudova Dilnoza Yunusovna Andizhan State Medical Institute Assistant of Department of neurology Uzbekistan. Andizhan. Email address: mdyu87@mail.ru (Maksudova Dilnoza Yunusovna) To cite this article: Maksudova Dilnoza Yunusovna. Ñomparative efficiency of neuroprotective, glutamatergic and complex of patients with vascular. Journal of research in health science. Vol. 1, No. 2, 2018, pp. 79-84. DOI 10.26739/2523-1243 http://dx.doi.org/10.26739/2523-1243/-2018-1-2-13 Abstract: The problem of in modern medicine becomes one of the most topical problems of nowdays which is associated with marked life quality aggravation of patients suffering from this disease and their disablement. Keywords: Dementia, scales,, cognitive disorders, post-stroce, subcortical. The article covers the issues related to development of þ. A clinical syndrome characterized by acquired progressive cognitive dysfunction. Not associated with normal age-specific, which affects social adaptation of patients[2]. The author provides accurate definition of mild cognitive disorders as clinical condition, presents its diagnostic criteria and types, as well as diagnostic criteria for associated whith Alzheimer disease, and vascular [1]. The 2nd type diabetes mellitus and cognitive disorders are two most rapid chronic conditions, determining at patients of older 60 years. At this age period DM is found at 18-20% of patients, cognitive disorders - on average, at 25% of patients, including at 6 % of patients, and moderate cognitive disorders at 19 % of patients[4]. For last years prevalence and, respectively, social value of both conditions are increasing for the reason of increasing the number of old people among population. Study of connection between cognitive disorders and DM may help to find one of the ways, preventing from increasing of sickness rate with which, according to the opinion of some specialists, has "chances" to become the main "epidemic" of the XXI century [3]. The analysis of comparative efficiency of various types of in patients with 79

Maksudova Dilnoza Yunusovna. Ñomparative efficiency of neuroprotective, glutamatergic and complex of patients with vascular diabetic has revealed differences in preparations effect on cognitive and functional constituents depending on the clinical form, gravity and stage of [5]. Comparison of influence efficiency of the studied therapeutic methods according to MMSE scale indicated rather early and evident Gliatiline effect on reliable improvement of overall estimate at the early stage of treatment in diabetic of mild form. At the furthest stage of attendance the Gliatiline influence on improvement of overall estimate has been considerably marked in subcortical irrespective of the case severity. At the completive stage of attendance the complex with Gliatiline and Alz epile in pat ient s wi th mild postapoplectic has been occurred to be more effective with regard to scale overall estimate. Table 1. Comparative efficiency of preparations according to MMSE (total number in a scale) in patients with diabetic at the beginning and end of the attendance. (M± δ) start Subcortocal mild 21,6±3,9 деменция moderatee 15,8±2,2 Post-stroce mild 22,1±3,8 Gliatiline ending-е 25,7±4,1 18,8±3,0 5 25,8±4,8 start ending start 21,8±2,9 22,2±3,1 22,1±2,9 Gliatiline + ending 26,7±3,7 15,2±2,9 16,1±2,5 15,4±1,9 17,1±2,2 22,4±2,7 25,6±4,2 21,2±2,8 moderatee 15,8±2,6 17,3±3,5 16,5±2,9 17,0±2,45 17,1±2,9 25,2±3,4 17,6±3,5 Note: differences as compared with the beginning of are authentic. ð<0,05, ð<0,01, ð<0,001 Comparison of influence efficiency of the three treating methods on separate indices of MMSE scale showed rather early and marked Gliatiline effect on indices of orientation and attention in subcortical irrespective of the case severity, but the preparation influence on information reproduction index has been rather evident in moderate subcortical. In postapoplectic Gliatiline effect occurred to be more effective on speech function. The complex with Gliatiline and proved to have more evident effect on speech indices irrespective of severity in its every clinical form. In mild postapoplectic the effect of complex has been marked on remembering index, in moderate at the furthest stage of the attendance the attention index has been more improved. Improvement of orientation and speech indices have been occurred in in subcortical and postapoplectic, but in comparison with the effect of the complex and Gliatiline the effect of on the given indices has been occurred to be less marked. In every form of moderate proved to be evidently marked on memorization index. 80

Journal of research in health science. 2018; 1 (2): 79-84. In every type of over the period of three year-observation some changes in gravity have been taken place in groups of patients of every clinical form of. At the completive stage of three year-observation and in 62 patients (44,3%) with mild the overall estimate according to MMSE scale has composed more than 24 points, i.e. severity of cognitive disturbances in these patients turned to be exceeded the limits of, in 31 (43,05%) patients out of them with subcortical and in 31 patients (45,6%) - with postapoplactic. In patients with mild form of, irrespective of the clinical form, complex with Gliatiline and proved to be more effective with regard to the influence on the severity of, in patients with subcortical - with Gliatiline, in patients with postapoplactic - with. (Table 12.) Òàble 2 Influence of various types of on changes of severity over the course of observation period MMSE, total score Initiation of End of 20-24 score 20-24 балла > 24 баллов Gliatiline 24 (100%) 13 (54,2%) 11 (45,8%) Subcortocal 24 (100%) 21 (87,5%) 3 (12,5%) Gliatiline + 24 (100%) 5 (29,2%) 17 (70,8%) Gliatiline 23 (100%) 15 (65,2%) 8 (34,8%) Post-stroce 23 (100%) 12 (52,2%) 11 (47,8%) Gliatiline + 22 (100%) 10 (45,5%) 12 (54,5%) At the completive moment of three year - observation period and in 31 patients (23,5%) with mild the overall estimate according to MMSE scale has composed more than 19 points, i.e. gravity has been changed to the mild case, in 15 patients out of them (20,8%) - with subcortical and in 16 patients (26,6%) - with postapoplactic. In patients with moderate, irrespective of the clinical form, with Gliatiline has been occurred to be more effective with regard to the influence on the severity of. (Table 13). 81

Maksudova Dilnoza Yunusovna. Ñomparative efficiency of neuroprotective, glutamatergic and complex of patients with vascular Òable 3 Influence of various types of on changes of severity over the course of observation period MMSE, total score Initiation of End of 10-19 score 10-19 баллов > 19 баллов Gliatiline 24 (100%) 14 (58,4%) 10 (41,6%) Subcortocal 24 (100%) 24 (100%) 0,number of patients, (n,%) Gliatiline + 24 (100%) 19 (79,2%) 5 (20,8%) Gliatiline 20 (100%) 14 (70%) 6 (30,0%) Post-stroce, number of patients, (n,%) 19 (100%) 15 (78,9%) 4 (21,05%) Gliatiline + 21 (100%) 15 (71,4%) 6 (28,6%) the according to ADAS-cog+ scale has shown considerably marked effect of the complex with Gliatiline and on reducing the total number in a scale at the early stage of irrespective of gravity in its every clinical form. In subcortical moderate the influence of the given type of on reducing the total number in a scale at the furthest stage of attendance proved to be more clearly marked than the influence by Gliatiline and. At the furthest stage of attendance the effect of Gliatiline on reducing the total number in a scale has turned out to be considerably marked in mild cases of subcortical and moderate postapoplactic, and has hàd more evident effect on reducing the total number in a scale in case of mild postapoplactic (Table 14). 82

Journal of research in health science. 2018; 1 (2): 79-84. Table 4 Comparative efficiency of preparations according to ADAS-cog (total number in a scale) in patients with diabetic at the beginning and end of observation. (M±δ) Gliatiline Gliatiline + Initiation of End of Initiation of End of Initiation of End of mild 23,8±5,4 11,2±1,5 24,0±5,1 18,6±4,5 23,3±5,9 12,7±4,3 Subcortocal moderate 37,2±10,5 25,2±7,3 29,2±9,25 21,3±5,5 31,5±8,5 17,5±2,1 mild 23,1±7,4 13,25±7,6 26,0±8,4 14,0±4,3 18,4±3,9 9,8±1,8 Post- stroce moderate 27,6±7,7 15,8±8,4 28,5±4,7 18,0±2,75 28,0±4,75 17,0±2,5 Note: differences as compared with the beginning of are authentic. ð<0,05, ð<0,01, ð<0,001 While compar in g the in fluenc e efficiency of the three therapeutic methods on separate indices of ADAS-cog+ scale it has been revealed rather early and marked Gliatiline effect on indices of memory, learning, acquisition of new information, constructive praxis and executive functions in case of mild irrespective of the clinical form. Complex with Gliatiline and at the furthest stage of attendance proved to have rather evident influence on visual attention regardless of gravity in its every form. In case of mild subcortical - on praxis indices. By means of complex in every clinical form of at the furthest stage of attendance the improvement of indices of memory, learning, acquisition of new information have been noted, but in comparison with the effect of Gliatiline, the effect of complex on the given indices has been less marked. has greater influence on improvement the indices of praxis and understanding of the speech in moderate subcortical, in postapoplactic the improves the indices of visual attention as well as with complex treatment improves the indices of executive functions. the according to ÌîÑà test scale has shown, that Gliatiline has rather early and marked influence on the indices of intellectual functioning of patients in subcortical irrespective of the case severity. In postapoplactic Gliatiline has more effect on the indices of every-day and motional activities. Complex with Gliatiline and at the early stage mostly 83

Maksudova Dilnoza Yunusovna. Ñomparative efficiency of neuroprotective, glutamatergic and complex of patients with vascular influences on the patient's abilities for self-service and self-care, motional activity and daily contact in every clinical form of irrespective of the case severity. influences on improvement of indices of intellectual functioning of patients, common and motional activities in every form of, but in comparison with the effect of complex with Gliatiline, the effect of on the given indices has been less marked. therapeutic methods on the rate of cognit ive processes and executi ve functions of patients has showed rather early and greater effect of Gliatiline in every clinical form of mild. At the the furthest stage Gliatiline effect proved to be considerably evident in mild subcortical, and in moderate subcortical - the effect of complex by preparations. therapeutic methods on optical-space gnosis has revealed rather early and greater influence of Gliatiline in postapoplactic irrespective of the case severity. At the the furthest stage of at tendan ce Alz epile effect on improvement test estimation has been greater marked than the effect of complex and Gliatiline. Influence of the complex by preparations on the space functions in subcortical proved to be considerably marked as well as at the early stage and at the furthest stage of attendance irrespective of gravity. References: 1. DCCT Research Group. Effects of intensive diabetes neuropsychological function in adults in the Diabetes Control and Complications Trial.// Ann. Intern. Med. -1996.-Vol. 124. - P.379-388. 2. CCT Research Group. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. // New England Journal of Medicine. 3. Gregg E.W., Engelgau M.E., Narayan K.M.V. Cognitive decline, physical disability, and other unappreciated outcomes of diabetes and aging. // BMJ. 2002. - Vol.325.-P.916-917 4. Petersen R. S. Current concepts in mild cognitive impairment // Arch. Neurol. 2001. - Vol. 58. - P. 1985-1992. 5.Posner H.B., Tang M.-X., Luchsinger J.The relationship of hypertension in the elderly to AD, vascular, and cognitive function // Neurology. Vol. 2002 (58) P.1175-1181. 84